We are trialling new drug that could help immune system beat cancer
Posted 24th February 2016
The Clatterbridge Cancer Centre, with colleagues at Aintree, is one of just three centres in the UK participating in a pioneering clinical trial of a drug that could stop a patient’s immune system from protecting tumours.
The Phase 2 clinical trial of a drug called AMG319, produced by Amgen, will find out whether it removes the defence shield that hides cancer cells from the immune system. It involves around 54 patients – here, in Southampton and in Poole – who have a particular type of throat or mouth cancer called squamous cell carcinoma.
You can read more about the trial, which has been launched by Cancer Research UK’s Centre for Drug Development in partnership with Amgen Inc, on the Cancer Research UK website.
Read their news story. http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2016-02-24-cancer-research-uk-launches-trial-for-potential-new-drug-that-could-help-immune-system-fight-cancer
Read their blog. http://scienceblog.cancerresearchuk.org/2016/02/24/opening-a-window-of-opportunity-for-head-and-neck-cancer/